Bener, A. Et Al. 2014. Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome. Journal of Primary Care & Community Health , vol.5, no.3 , 180-187.

Bener, A., Doğan, M., Barakat, L., & Al Hamaq, A. O., (2014). Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome. Journal of Primary Care & Community Health , vol.5, no.3, 180-187.

Bener, Abdulbari Et Al. "Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome," Journal of Primary Care & Community Health , vol.5, no.3, 180-187, 2014

Bener, Abdulbari Et Al. "Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome." Journal of Primary Care & Community Health , vol.5, no.3, pp.180-187, 2014

Bener, A. Et Al. (2014) . "Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome." Journal of Primary Care & Community Health , vol.5, no.3, pp.180-187.

@article{article, author={Abdulbari Bener Et Al. }, title={Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome}, journal={Journal of Primary Care & Community Health}, year=2014, pages={180-187} }